Skip to content

Author

Drashti Shah

We have 4 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Green Synthetic Strategies for Indole Derivatives: A Sustainable Approach

Indole, a prominent bicyclic heteroaromatic scaffold, has attracted significant attention due to its wide-ranging biological, pharmaceutical, and industrial relevance. This review summarizes key advancements made between 2014 and 2025 in the green synthesis of indole derivatives, emphasizing the growing importance...

Ashish Patel, Dharti Patel, Krishi Patel et al. · 0 citations
Review Sep 2026

Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances.

INTRODUCTION Angiogenesis, primarily controlled by Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2), significantly influences tumor growth and metastasis. Consequently, VEGFR-2 targeting has emerged as an important strategy for cancer treatment. Owing to their known efficacy as strong tyrosine kinase inhibitors,...

A. Yadav, Drashti Shah, Princy Desai et al. · 0 citations
Review Jul 2026

Recent advances in 1,3,5-triazine-based PI3K inhibitors for cancer therapy: a comprehensive review.

This comprehensive review critically summarizes advances from 2021-2025 in the design of selective PI3K inhibitors based on the 1,3,5-triazine (s-triazine) scaffold, emphasizing how its symmetric 2/4/6 substitution vectors, electron-deficient hinge-binding profile, and modular cyanuric chloride - enabled SNAr synthesis...

Utkarsha Kulkarni, Adarsh Yadav, Princy Desai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.